NDAQ vs RGNX · P/E 41, rev $2.53B vs rev $114.4M
Nasdaq Inc (NDAQ) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the NDAQ and RGNX stock pages for the full models.
Not investment advice.